Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Sales | 591.63 | 696.41 | 625.53 | 624.83 | 551.20 |
| Operating profit | 71.90 | 88.52 | 68.98 | 70.18 | 54.73 |
| Interest | 7.77 | 8.35 | 9.12 | 8.27 | 6.79 |
| Gross profit | 64.79 | 81.10 | 60.83 | 62.00 | 48.18 |
| EPS (Rs) | 4.27 | 5.74 | 3.96 | 3.95 | 2.85 |
Quarterly
results in details
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Other income | 0.66 | 0.93 | 0.97 | 0.09 | 0.24 |
| Stock adjustment | -7.28 | 44.67 | 23.67 | -15.16 | -59.90 |
| Raw material | 399.02 | 435.39 | 401.46 | 435.56 | 430.03 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 20.66 | 21.10 | 19.15 | 17.93 | 16.81 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 107.33 | 106.73 | 112.27 | 116.32 | 109.53 |
| Provisions made | - | - | - | - | - |
| Depreciation | 11.75 | 11.68 | 11.87 | 11.92 | 11.83 |
| Taxation | 13.50 | 16.25 | 12.25 | 13.50 | 10.00 |
| Net profit / loss | 39.54 | 53.17 | 36.71 | 36.58 | 26.35 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 92.60 | 92.60 | 92.60 | 92.60 | 92.60 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 12.15 | 12.71 | 11.03 | 11.23 | 9.93 |
| GPM (%) | 10.94 | 11.63 | 9.71 | 9.92 | 8.74 |
| NPM (%) | 6.68 | 7.62 | 5.86 | 5.85 | 4.78 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis